Hasil Pencarian - Xingxiang Pu

Perbaiki Hasil
  1. 1
    Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance

    Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance oleh Xingxiang Pu, Lin Wu, Dan Su, Weimin Mao, Bingliang Fang

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Case Report: Tissue Origin Identification for Cancer of Unknown Primary: Gene Expression Profiling Approach

    Case Report: Tissue Origin Identification for Cancer of Unknown Primary: Gene Expression Profiling Approach oleh Xingxiang Pu, Sa Yang, Yan Xu, Bolin Chen, Qianzhi Wang, Qian Gong, Lin Wu

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    A real‐world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non‐small cell lung cancer

    A real‐world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non‐small cell lung cancer oleh Baihua Zhang, Haifan Xiao, Xingxiang Pu, Chunhua Zhou, Desong Yang, Xu Li, Wenxiang Wang, Qin Xiao

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Perivascular epithelioid cell tumor of the lung: A case report and literature review

    Perivascular epithelioid cell tumor of the lung: A case report and literature review oleh Shaofu Yu, Shasha Zhai, Qian Gong, Xiaoping Hu, Wenjuan Yang, Liyu Liu, Yi Kong, Lin Wu, Xingxiang Pu

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort study

    Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort study oleh Xingxiang Pu, Yu Zhou, Yi Kong, Bolin Chen, Aifang Yang, Jia Li, Kang Li, Yan Xu, Lin Wu

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Computed tomography-based radiomics quantification predicts epidermal growth factor receptor mutation status and efficacy of first-line targeted therapy in lung adenocarcinoma

    Computed tomography-based radiomics quantification predicts epidermal growth factor receptor mutation status and efficacy of first-line targeted therapy in lung adenocarcinoma oleh Meilin Jiang, Pei Yang, Pei Yang, Jing Li, Wenying Peng, Xingxiang Pu, Bolin Chen, Jia Li, Jingyi Wang, Lin Wu

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.

    Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis. oleh Dan Liao, Yongfu Wu, Xingxiang Pu, Hua Chen, Shengqun Luo, BinBin Li, Congcong Ding, Guo-Liang Huang, Zhiwei He

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathway

    ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathway oleh Wei Zhai, Wensheng Yang, Jing Ge, Xuelian Xiao, Kang Wu, Kelin She, Yu Zhou, Yi Kong, Lin Wu, Shiya Luo, Xingxiang Pu

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study

    Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study oleh Meiting Chen, Yungchang Chen, Xiaojie Fang, Zhao Wang, Xingxiang Pu, Chaoyong Liang, Hongqiang Guo, Qian Li, Fei Pan, Huangming Hong, He Huang, Jiman Li, Tongyu Lin

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    High‐throughput sequencing detection and ensartinib treatment of lung cancer harboring NTRK1 fusion

    High‐throughput sequencing detection and ensartinib treatment of lung cancer harboring NTRK1 fusion oleh Zhengbo Song, Chunwei Xu, Xingxiang Pu, Youcai Zhu, Wenxian Wang, Xingliang Li, Yanqiu Gao, Wenliang Zhu, Yunwei He, Lin Wu, Li Mao, Li Chen, Ming Chen

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy

    Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy oleh Meilin Jiang, Wenying Peng, Xingxiang Pu, Bolin Chen, Jia Li, Fang Xu, Liyu Liu, Li Xu, Yan Xu, Jun Cao, Qianzhi Wang, Kang Li, Jingyi Wang, Lin Wu

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Rh‐endostatin plus camrelizumab and chemotherapy in first‐line treatment of advanced non‐small cell lung cancer: A multicenter retrospective study

    Rh‐endostatin plus camrelizumab and chemotherapy in first‐line treatment of advanced non‐small cell lung cancer: A multicenter retrospective study oleh Xingxiang Pu, QianZhi Wang, Liyu Liu, Bolin Chen, Kang Li, Yu Zhou, Zengmei Sheng, Ping Liu, Yucheng Tang, Li Xu, Jia Li, Yi Kong, Fang Xu, Yan Xu, Lin Wu

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy

    Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy oleh Xiang Yan, Li Wang, Ran Zhang, Xingxiang Pu, Shuhong Wu, Lili Yu, Ismail M. Meraz, Xiaoshan Zhang, Jacqueline F. Wang, Don L. Gibbons, Reza J. Mehran, Stephen G. Swisher, Jack A. Roth, Bingliang Fang

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Prevalence and clinical significance of pathogenic germline <i>BRCA1</i>/<i>2</i> mutations in Chinese non-small cell lung cancer patients

    Prevalence and clinical significance of pathogenic germline <i>BRCA1</i>/<i>2</i> mutations in Chinese non-small cell lung cancer patients oleh Xingsheng Hu, Dongyong Yang, Yalun Li, Li Li, Yan Wang, Peng Chen, Song Xu, Xingxiang Pu, Wei Zhu, Pengbo Deng, Junyi Ye, Hanhan Zhang, Analyn Lizaso, Hao Liu, Xinru Mao, Hai Huang, Qian Chu, Chengping Hu

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

    Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer oleh Xingxiang Pu, Ran Zhang, Li Wang, Yungchang Chen, Yi Xu, Apar Pataer, Ismail M. Meraz, Xiaoshan Zhang, Shuhong Wu, Lin Wu, Dan Su, Weimin Mao, John V. Heymach, Jack A. Roth, Stephen G. Swisher, Bingliang Fang

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients

    Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients oleh Xingsheng Hu, Dongyong Yang, Yalun Li, Li Li, Yan Wang, Peng Chen, Song Xu, Xingxiang Pu, Wei Zhu, Pengbo Deng, Junyi Ye, Hanhan Zhang, Analyn Lizaso, Hao Liu, Xinru Mao, Hai Huang, Qian Chu, Chengping Hu

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II studyResearch in context

    Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II studyResearch in context oleh Xingxiang Pu, Gen Lin, Maoliang Xiao, Jie Lin, Qianzhi Wang, Yi Kong, Xuejun Yan, Fang Xu, Yan Xu, Jia Li, Kang Li, Bolin Chen, Xiaoping Wen, Yali Tan, Fengzhuo Cheng, Kangle Zhu, Na Li, Lin Wu

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses

    The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses oleh Yungchang Chen, Hao Sun, Yanhong Deng, Yutong Ma, He Huang, Yang Liu, Yaru Zhang, Hongyu Zhang, Sheng Ye, Mingyan E, Hongqiang Guo, Mengmeng Wu, Chunman Wu, Xingxiang Pu, Xinggui Chen, Chaoyong Liang, Qiuxiang Ou, Huawei Weng, Xue Wu, Yang Shao, Anxin Gu, Tongyu Lin

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Clinical and genomic features of Chinese lung cancer patients with germline mutations

    Clinical and genomic features of Chinese lung cancer patients with germline mutations oleh Wenying Peng, Bin Li, Jin Li, Lianpeng Chang, Jing Bai, Yuting Yi, Rongrong Chen, Yanyan Zhang, Chen Chen, Xingxiang Pu, Meilin Jiang, Jia Li, Rui Zhong, Fang Xu, Bolin Chen, Li Xu, Ning Wang, Jiaojiao Huan, Pingping Dai, Yanfang Guan, Ling Yang, Xuefeng Xia, Xin Yi, Jiayin Wang, Fenglei Yu, Lin Wu

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor

    Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor oleh Wenxian Wang, Qian Wang, Chunwei Xu, Ziming Li, Zhengbo Song, Yongchang Zhang, Xiuyu Cai, Shirong Zhang, Bin Lian, Wen Li, Anwen Liu, Ping Zhan, Hongbing Liu, Tangfeng Lv, Liyun Miao, Lingfeng Min, Yu Chen, Jingping Yuan, Feng Wang, Zhansheng Jiang, Gen Lin, Xingxiang Pu, Chuangzhou Rao, Dongqing Lv, Zongyang Yu, Xiaoyan Li, Chuanhao Tang, Chengzhi Zhou, Congying Xie, Junping Zhang, Hui Guo, Qian Chu, Rui Meng, Jingxun Wu, Rui Zhang, Liping Wang, Youcai Zhu, Xiao Hu, Yanru Xie, Xinqing Lin, Jing Cai, Fen Lan, Huijing Feng, Lin Wang, Wang Yao, Xuefei Shi, Jianhui Huang, Huafei Chen, Yinbin Zhang, Pingli Sun, Bing Wan, Fei Pang, Zanmei Xu, Kai Wang, Yuanli Xia, Mingxiang Ye, Dong Wang, Qing Wei, Shuitu Feng, Jianya Zhou, Jiexia Zhang, Donglai Lv, Wenbin Gao, Jing Kang, Genhua Yu, Xianbin Liang, Chengtao Yu, Lin Shi, Nong Yang, Lin Wu, Zhuan Hong, Wei Hong, Meiyu Fang, Yiping Zhang, Yuanzhi Lu, Guansong Wang, Shenglin Ma, Lu Si, Wenfeng Fang, Yong Song

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: